Drug Shortages Raise Concerns for Dental Sedation Providers

Learn which midazolam and flumazenil formulations remain available amid ongoing shortages, and how dental sedation providers can prepare.

By Genni Burkhart, Editor

Two medications important to dental sedation remain in short supply nationwide, with some manufacturers projecting delays into 2027. Midazolam, commonly used in IV sedation, and flumazenil, a benzodiazepine reversal agent, are both on the American Society of Health-System Pharmacists (ASHP) current drug shortage list.

Although some formulations remain available, ongoing manufacturing delays and increased demand have affected supplies. For dental practices offering oral or IV sedation, the shortages raise questions about medication availability, purchasing options, and emergency preparedness.

Which Sedation Medications Are Affected?

Earlier this month, the American Dental Association (ADA) alerted dentists to a national shortage of flumazenil, which reverses the effects of benzodiazepines used during sedation. The medication is especially important for emergency preparedness, and some states require dental sedation providers to keep it on hand.

According to ASHP's October 8 update, flumazenil supplies have improved since the ADA's October 1 report. Baxter, Fresenius Kabi, and Hikma now list certain vial sizes as available, although others remain on back order.

  • Baxter has 10 mL vials available, but its 5 mL vials remain on back order with no estimated release date.
  • Fresenius Kabi has 5 mL vials available and expects its 10 mL vials to return in early November.
  • Hikma has 5 mL vials available, while its 10 mL vials remain on back order, with an estimated return by late October.

Midazolam, another medication commonly used in IV sedation, is also affected. ASHP's September 30 update identifies shortages involving several manufacturers, including Pfizer, Fresenius Kabi, and Hikma.

Pfizer reports limited supplies of certain 1 mg/mL vials, with additional quantities released weekly. Its 10 mL vials remain on back order, with an estimated return in January 2027. The company also projects that certain 5 mg/mL vials won't be available until December 2026 or January 2027.

While other manufacturers report having midazolam available, practices may need to check with distributors about specific concentrations and vial sizes.

What's Behind the Shortages?

Manufacturing delays and increased demand are contributing to both shortages, though the circumstances differ by manufacturer. Baxter attributes its flumazenil shortage to manufacturing delays involving a third-party supplier. Fresenius Kabi and Hikma haven't identified specific causes for the shortages affecting their products. For midazolam, Pfizer reports manufacturing delays and increased demand. Fresenius Kabi cites increased demand and shipping delays, while Hikma also reports increased demand.

As a result, practices may face backorders or limited purchasing options even when other manufacturers continue supplying the same medication.

What Should Dental Practices Do?

For sedation providers, the immediate concern is maintaining access to the medications required for treatment and emergency preparedness. Even practices with adequate supplies should anticipate potential delays when placing future orders.

Dentists can take several practical steps to prepare.

  • Review inventory. Check quantities, expiration dates, concentrations, and vial sizes for midazolam and flumazenil.
  • Confirm availability. Contact distributors about current supply, backorders, purchasing limits, and expected delivery dates.
  • Consider available formulations. ASHP lists alternative manufacturers and vial sizes. Any substitution requires careful review of concentrations, dosing, and existing sedation protocols.
  • Review emergency preparedness. Confirm that required reversal medications and emergency equipment are available and that office protocols comply with applicable state regulations and sedation guidelines.

Practices can follow the latest manufacturer updates through the ASHP Drug Shortages List and the FDA Drug Shortages Database.

Many dental practices may have enough supplies for now, but with shortages expected to continue into 2027, it's worth monitoring availability. Staying informed and working closely with suppliers will also help sedation providers plan ahead and keep schedules running smoothly.

Author: With over 16 years as a published journalist, editor, and writer, Genni Burkhart's career has spanned politics, healthcare, law, business finance, technology, and news. She resides in Northern Colorado, where she works as the editor-in-chief of the Incisor at DOCS Education.

References

  1. Versaci, M. B. (2026, October 1). Manufacturers report flumazenil injection shortage. ADA News. https://adanews.ada.org/ada-news/2026/october/manufacturers-report-flumazenil-injection-shortage/
  2. American Society of Health-System Pharmacists. (2026, October 8). Flumazenil injection. Updated October 8, 2026 by Michelle Wheeler, PharmD, Drug Information Specialist. Created June 25, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2026, Drug Information Service, University of Utah, Salt Lake City, UT. https://www.ashp.org/drug-shortages/current-shortages/drug-shortage-detail.aspx?id=1226
  3. American Society of Health-System Pharmacists. (2026, September 30). Midazolam injection. Updated September 30, 2026 by Michelle Wheeler, PharmD, Drug Information Specialist. Created June 25, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2026, Drug Information Service, University of Utah, Salt Lake City, UT. https://www.ashp.org/drug-shortages/current-shortages/drug-shortage-detail.aspx?id=576
  4. American Dental Association. (2026). Anesthesia and sedation. https://www.ada.org/resources/ada-library/oral-health-topics/anesthesia-and-sedation
  5. U.S. Food and Drug Administration. FDA drug shortages database. https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm
DOCS Membership

Upcoming Events
Streaming
February 19- 20, 2027
NJ
March 19- 20, 2027
Streaming
May 21- 22, 2027

More Articles